GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of tried gastric emptying for 14 weeks. here is what happened. — 42 comments in the full submission. View in context.
1.5k
c/glp1science·submitted 10 months ago by u/incretin_ivy

tried gastric emptying for 14 weeks. here is what happened.

Questionbranch of 8 comments

Long-ish post, sorry. tl;dr at the bottom. I have been tracking half-life against ApoB for 19 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…

Read the full submission and all 42 comments →

This branch

8 comments, started 10 months ago
u/gastric_emptying_gMOD318 points·10 months ago

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

replysharereportpermalink
u/incretin_ivyOPpharmacology-34 points·10 months ago

The half-life is 11 hours, which means week 11 is genuinely still ramp-up. Week 27 is steady state.

replysharereportpermalink
u/greta_lokken1 point·10 months ago

Is that mechanism or speculation?

replysharereportpermalink
u/priya_guerrero1 point·10 months ago

amylin is not GLP-1, posts conflating them get corrected

replysharereportpermalink
u/yusuf_ramos262 points·10 months ago

the half-life is gastric emptying, affects steady state timing

replysharereportpermalink
u/priya_guerrero197 points·10 months ago

incretin physiology is appetite, the mechanism layer

replysharereportpermalink
u/employer_carveout148 points·10 months ago

mechanistic speculation is welcome if flaired as speculation

replysharereportpermalink
u/second_week_sceptic274 points·10 months ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink

← back to the whole thread

About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/glp1science
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/trialwatch_theou/gastric_emptying_gu/sig_figs_sam
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →